The immediate efficacy of inhaled nitric oxide treatment in preterm infants with acute respiratory failure during neonatal transport.
Felipe GarridoJuan Luis González CaballeroRachel LomaxIan DadyPublished in: Acta paediatrica (Oslo, Norway : 1992) (2019)
Following the recommendations of the American Academy of Paediatrics and other organizations, iNO should not routinely be used during the neonatal transfer of preterm babies <34+0 in respiratory failure. We need to conduct further studies to establish which selected preterm patients would benefit from being treated with iNO.
Keyphrases
- respiratory failure
- extracorporeal membrane oxygenation
- preterm infants
- low birth weight
- mechanical ventilation
- nitric oxide
- end stage renal disease
- gestational age
- newly diagnosed
- ejection fraction
- preterm birth
- acute respiratory distress syndrome
- chronic kidney disease
- peritoneal dialysis
- intensive care unit
- prognostic factors
- cystic fibrosis
- liver failure
- patient reported
- hepatitis b virus
- case control
- replacement therapy